NEWSNATIONNOW (Josie Fischels) - GLP-1-driven vitamin deficiency linked to rare brain disorder: Study
Researchers found a rare but potentially life-threatening brain disorder in a small number of people taking Ozempic, Wegovy and similar drugs.
Researchers found a rare but potentially life-threatening brain disorder in a small number of people taking Ozempic, Wegovy and similar drugs.
Author Da'Shaun L. Harrison claims that the use of GLP-1 weight loss medications operates as 'body fascism.' #fox #foxnews #media #breakingnews #us #usa #new #news #breaking #dashaunharrison #harrison #glp1 #weightloss #weightlossmedication #health #healthnews #obesity #bodyimage #medicine #healthcare #medicalnews #diet #wellness #controversy #healthyliving #prescriptiondrugs Don’t just watch Fox News—be part of it. Become a Fox News Patriot today. https://youtube.com/foxnews/join
There are troubling new signs that the overhaul of Medicare drug coverage in the Inflation Reduction Act is dramatically driving up program spending. Why it matters: The upward trajectory could threaten some seniors' coverage for outpatient prescription drugs — and it could force painful tradeoffs over the next decade as Medicare consumes a growing share of the nation's debt. Follow the money: The IRA limited what seniors have to pay for outpatient drugs and shifted the remaining cost to taxpayers, insurers who provide stand-alone Medicare drug plans and drug manufacturers. - That was good news for enrollees who take expensive drugs for conditions like cancer, multiple sclerosis or rheumatoid arthritis and faced potentially crushing…
A societal spotlight on extreme thinness is stripping body diversity from screens, just as fashion magazines did in the early aughts, mental health experts tell Axios. The big picture: Fake content creators are introducing unattainable, AI-generated body images that prey on human nature and exacerbate the struggle for many to reach self-acceptance for their bodies. - When shrunken celebrities "become the ideal ... because of their status, then the virtual influencers are going to be emulating that," Katy Bruchmann, who leads Santa Clara University's Social Cognition and Comparison Lab, says. - "Then, the more really thin, super beautiful virtual influencers you have, the target changes for all the real people again. It's a really scary…
Kids with obesity-related conditions like high cholesterol or sleep apnea were substantially more likely to be prescribed GLP-1s than those without.
Obstructive sleep apnea affects nearly one billion adults worldwide and is linked to serious health problems.
Today, the world has plenty of food. But practically everything needed to replace that food tomorrow is being disrupted—all at once. And curiously, we may be approaching the first food crisis in history where millions are paying hundreds of dollars a month for GLP-1 drugs designed to stop them from feeling hungry. In this video, we follow the pressure building across the food system—from fertilizer and farmland to livestock, grain traders, cargo ships and grocery-store shelves—to understand why the next food crisis may already be taking shape. Because one isolated disruption is manageable. The problem is that these disruptions are no longer isolated. Buy The Deep State Encyclopedia: Exposing the Cabal's Playbook…
Watch Final Hours https://ept.ms/WatchFullFinalHours Up to $20,000 of Free Silver: https://ept.ms/3biH9MN How badly do you want that perfect beach body? Some are willing to get liposuction and have someone shuffle their own fat around. But how about getting one’s body enhanced by injecting fat from dead people? Is that a bit much? Well, that’s what’s happening in the cosmetics industry. Now, you might ask: Why do they need to use fat from cadavers? Why not just liposuction one area, and move it to another? Here’s the twist: the rise of GLP-1 weight loss drugs are leaving people without enough fat to move around. Let’s go through it all together. #botox #cosmeticsurgery #fat #factsmatter © All Rights Reserved.
Employer health insurance costs are expected to spike by 8.2%, the highest costs in decades, according to a survey conducted by Marsh. The price increase is caused by hospital consolidation, specialty and GLP drugs, and high-cost claimants.
With 5.5% of Brazil's population using GLP-1s, smugglers are profiting from the illegal movement and sales of medication